Ross E. McKinney, Jr., M.D. Safety and Tolerance of Zidovudine (ZDV, AZT, RETROVIR) During a Phase I Study in Children: Two Year Follow-Up.
Citation
A. Kavanaugh-mchuch. Cardiac Abnormalities in Pediatric HIV Infection.
Citation
Peggy Weintrub, M.D. Safety and Pharmacokinetics of Recombinant CD4 in Children with HIV Infection.
Citation
Dorothy E. Lewis, Ph.D. Diagnosis of HIV Infection in Early Infancy; HIV Culture, Polymerase Chain Reaction (PCR), HIV+ Specific IgA Antibody.
Citation
Michael T. Brady, M.D. Controlled Trial of Tolerance and Efficacy of Zidovudine (ZDV) at Standard and Low Dose in Children (ACTG 128).
Citation
James M. Oleske, M.D. PCP Prophylaxis (PRO) Among Children Followed in ACTG Pediatric Long-Term Protocol 219.
Citation
Stephen A. Spector, M.D. Results of a Clinical Trial Comparing Two Doses of 2'3'-Dideoxyctidine (ddC) in the Treatment of Children with Symptomatic Human Immunodeficiency Virus (HIV) Infection who Were Intolerant or Had Failed Zidovudine (ZDV) Therapy (ACTG 138).
Citation
Russell B. Van Dyke, M.D. Pharmacokinetics (PK) and Tolerance of Intravenous Pentamidine (IV-P) in HIV-Infected Children.
Citation
Janet Ailene Englund, M.D. Laboratory Characteristics of Children Enrolled into a Randomized, Double-Blind Trial of Antiretroviral Therapy (ACTG 152).
Citation
Robert Husson, M.D. Simultaneous Combination Therapy with Zidovudine (AZT) and Dideoxyinosine (ddI) in Children with HIV Infection.